{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:50:31Z","timestamp":1793155831857,"version":"4.5.0"},"reference-count":229,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022A1515110809"],"award-info":[{"award-number":["2022A1515110809"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011478","name":"Foshan Science and Technology Bureau","doi-asserted-by":"publisher","award":["2220001005369, 2320001007101, 2320001007336"],"award-info":[{"award-number":["2220001005369, 2320001007101, 2320001007336"]}],"id":[{"id":"10.13039\/501100011478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010883","name":"Traditional Chinese Medicine Bureau of Guangdong Province","doi-asserted-by":"publisher","award":["202305041559305920"],"award-info":[{"award-number":["202305041559305920"]}],"id":[{"id":"10.13039\/501100010883","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Emerging evidence indicates a correlation between inflammation and the development and progression of cancer. Among the various inflammatory signals, interleukin-17 (IL-17) family cytokines serve as a critical link between inflammation and cancer. IL-17 is a highly versatile pro-inflammatory cytokine that plays a pivotal role in host defense, tissue repair, the pathogenesis of inflammatory diseases, and cancer progression. During the early stages of tumorigenesis, IL-17 signaling directly promotes the proliferation of tumor cells. Conversely, IL-17 has been shown to exhibit antitumor immunity in several models of grafted subcutaneous tumors. Additionally, dynamic changes in the microbiome can influence the secretion of IL-17, thereby affecting tumor development. The specific role of IL-17 is contingent upon its functional classification, spatiotemporal characteristics, and the stage of tumor development. In this review, we introduce the fundamental biology of IL-17 and the expression profile of its receptors in cancer, while also reviewing and discussing recent advancements regarding the pleiotropic effects and mechanisms of IL-17 in inflammation-related cancers. Furthermore, we supplement our discussion with insights into the mechanisms by which IL-17 impacts cancer progression through interactions with the microbiota, and we explore the implications of IL-17 in cancer therapy. This comprehensive analysis aims to enhance our understanding of IL-17 and its potential role in cancer treatment.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1479505","type":"journal-article","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T03:37:42Z","timestamp":1737430662000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":66,"title":["The role of interleukin-17 in inflammation-related cancers"],"prefix":"10.3389","volume":"15","author":[{"given":"Xingru","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conner","family":"Chiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kepeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.4110\/in.2020.20.e6","article-title":"IL-17-producing cells in tumor immunity: friends or foes","volume":"20","author":"Kuen","year":"2020","journal-title":"Immune Netw"},{"key":"B2","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","article-title":"The IL-17 family of cytokines in health and disease","volume":"50","author":"McGeachy","year":"2019","journal-title":"Immunity"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1107\/S1399004714005227","article-title":"Structure of the unique SEFIR domain from human interleukin 17 receptor A reveals a composite ligand-binding site containing a conserved alpha-helix for Act1 binding and IL-17 signaling","volume":"70","author":"Zhang","year":"2014","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"B4","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-023-01620-3","article-title":"The IL-17 family in diseases: from bench to bedside","volume":"8","author":"Huangfu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/ph15111365","article-title":"A review of the safety of interleukin-17A inhibitor secukinumab","volume":"15","author":"Eshwar","year":"2022","journal-title":"Pharm (Basel)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.900273","article-title":"Pan-cancer analysis reveals interleukin-17 family members as biomarkers in the prediction for immune checkpoint inhibitor curative effect","volume":"13","author":"Han","year":"2022","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.cyto.2015.09.011","article-title":"Interleukin-17 acts as double-edged sword in anti-tumor immunity and tumorigenesis","volume":"89","author":"Qian","year":"2017","journal-title":"Cytokine"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-03-208249","article-title":"Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments","volume":"114","author":"Kryczek","year":"2009","journal-title":"Blood"},{"key":"B9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ccell.2023.12.006","article-title":"Gut epithelial Interleukin-17 receptor A signaling can modulate distant tumors growth through microbial regulation","volume":"42","author":"Chandra","year":"2024","journal-title":"Cancer Cell"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2024.01.001","article-title":"Targeting interleukin-17 in radiation-induced toxicity and cancer progression","volume":"75","author":"Baindara","year":"2024","journal-title":"Cytokine Growth Factor Rev"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.10.6186","article-title":"IL-17 receptor knockout mice have enhanced myelotoxicity and impaired hemopoietic recovery following gamma irradiation","volume":"176","author":"Tan","year":"2006","journal-title":"J Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.9.5948","article-title":"IL-23 promotes maintenance but not commitment to the Th17 lineage","volume":"181","author":"Stritesky","year":"2008","journal-title":"J Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/srep14674","article-title":"IL-1beta promotes Th17 differentiation by inducing alternative splicing of FOXP3","volume":"5","author":"Mailer","year":"2015","journal-title":"Sci Rep"},{"key":"B14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4049\/jimmunol.0801986","article-title":"TGF-beta promotes Th17 cell development through inhibition of SOCS3","volume":"183","author":"Qin","year":"2009","journal-title":"J Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/ni1539","article-title":"TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology","volume":"8","author":"McGeachy","year":"2007","journal-title":"Nat Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/nri2742","article-title":"T(H)17 cells in tumour immunity and immunotherapy","volume":"10","author":"Zou","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"B17","article-title":"Th17 cells associated cytokines and cancer","volume":"20","author":"Feng","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/314620","article-title":"Th17 cell plasticity and functions in cancer immunity","volume":"2015","author":"Guery","year":"2015","journal-title":"BioMed Res Int"},{"key":"B19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cellimm.2017.10.015","article-title":"The paradox of Th17 cell functions in tumor immunity","volume":"322","author":"Asadzadeh","year":"2017","journal-title":"Cell Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.06.010","article-title":"CD8(+) T cells that produce interleukin-17 regulate myeloid-derived suppressor cells and are associated with survival time of patients with gastric cancer","volume":"143","author":"Zhuang","year":"2012","journal-title":"Gastroenterology"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1600061","article-title":"CD8+ T cells that coexpress RORgammat and T-bet are functionally impaired and expand in patients with distal bile duct cancer","volume":"198","author":"Chellappa","year":"2017","journal-title":"J Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2008.12.033","article-title":"Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients","volume":"50","author":"Zhang","year":"2009","journal-title":"J Hepatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-327855","article-title":"IL-17A-producing CD8(+) T cells promote PDAC via induction of inflammatory cancer-associated fibroblasts","volume":"72","author":"Picard","year":"2023","journal-title":"Gut"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0902995","article-title":"Adoptive transfer of tumor-specific Tc17 effector T cells controls the growth of B16 melanoma in mice","volume":"184","author":"Garcia-Hernandez","year":"2010","journal-title":"J Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3109\/08830185.2014.954698","article-title":"Tc17 cells in immunity and systemic autoimmunity","volume":"34","author":"Liang","year":"2015","journal-title":"Int Rev Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202048627","article-title":"Tc17 biology and function: Novel concepts","volume":"50","author":"Luckel","year":"2020","journal-title":"Eur J Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1104730","article-title":"PD-1 limits differentiation and plasticity of Tc17 cells","volume":"14","author":"Arra","year":"2023","journal-title":"Front Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-022-00722-1","article-title":"The emerging roles of gammadelta T cells in cancer immunotherapy","volume":"20","author":"Mensurado","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1098847","article-title":"gammadelta T cells and their clinical application in colon cancer","volume":"14","author":"Corsale","year":"2023","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.cell.2018.12.040","article-title":"Commensal Microbiota Promote Lung Cancer Development via gammadelta T Cells","volume":"176","author":"Jin","year":"2019","journal-title":"Cell"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/nature14282","article-title":"IL-17-producing gammadelta T cells and neutrophils conspire to promote breast cancer metastasis","volume":"522","author":"Coffelt","year":"2015","journal-title":"Nature"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.10.041","article-title":"gammadelta T cells support pancreatic oncogenesis by restraining alphabeta T cell activation","volume":"183","author":"Daley","year":"2020","journal-title":"Cell"},{"key":"B33","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.immuni.2014.03.013","article-title":"gammadeltaT17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer","volume":"40","author":"Wu","year":"2014","journal-title":"Immunity"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1403424111","article-title":"Murine CD27(-) Vgamma6(+) gammadelta T cells producing IL-17A promote ovarian cancer growth via mobilization of protumor small peritoneal macrophages","volume":"111","author":"Rei","year":"2014","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/1292404","article-title":"CD4(+) CD25(high)CD127(low\/-) foxP(3)(+) regulatory T cell subpopulations in the bone marrow and peripheral blood of children with ALL: brief report","volume":"2018","author":"Niedzwiecki","year":"2018","journal-title":"J Immunol Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.4565","article-title":"Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection","volume":"25","author":"Gao","year":"2007","journal-title":"J Clin Oncol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.03.102","article-title":"Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients","volume":"132","author":"Fu","year":"2007","journal-title":"Gastroenterology"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-2360","article-title":"Regulatory T cells recruited through CCL22\/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome","volume":"69","author":"Gobert","year":"2009","journal-title":"Cancer Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.05.9584","article-title":"Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse","volume":"24","author":"Bates","year":"2006","journal-title":"J Clin Oncol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201847659","article-title":"Targeting Treg cells in cancer immunotherapy","volume":"49","author":"Tanaka","year":"2019","journal-title":"Eur J Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-2907","article-title":"Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer","volume":"71","author":"Tosolini","year":"2011","journal-title":"Cancer Res"},{"key":"B42","doi-asserted-by":"publisher","first-page":"3998","DOI":"10.1158\/0008-5472.CAN-04-3104","article-title":"CD4+CD25+ regulatory lymphocytes induce regression of intestinal tumors in ApcMin\/+ mice","volume":"65","author":"Erdman","year":"2005","journal-title":"Cancer Res"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-1511","article-title":"Adenomatous polyps are driven by microbe-instigated focal inflammation and are controlled by IL-10-producing T cells","volume":"73","author":"Dennis","year":"2013","journal-title":"Cancer Res"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s12272-022-01389-z","article-title":"Crosstalk between angiogenesis and immune regulation in the tumor microenvironment","volume":"45","author":"Kim","year":"2022","journal-title":"Arch Pharm Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1408710","article-title":"Interleukin-17 directly stimulates tumor infiltrating Tregs to prevent cance development","volume":"15","author":"Theune","year":"2024","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1094823","article-title":"The role of Th-17 cells and IL-17 in the metastatic spread of breast cancer: As a means of prognosis and therapeutic target","volume":"14","author":"Shibabaw","year":"2023","journal-title":"Front Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01371","article-title":"Myeloid-derived suppressor cells in tumors: from mechanisms to antigen specificity and microenvironmental regulation","volume":"11","author":"Yang","year":"2020","journal-title":"Front Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2018.148","article-title":"Regulatory T cells in the treatment of disease","volume":"17","author":"Sharabi","year":"2018","journal-title":"Nat Rev Drug Discovery"},{"key":"B49","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1189\/jlb.1RU0114-010RR","article-title":"IL-17+Foxp3+ T cells: an intermediate differentiation stage between Th17 cells and regulatory T cells","volume":"96","author":"Du","year":"2014","journal-title":"J Leukoc Biol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12943-016-0551-1","article-title":"Emerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasis","volume":"15","author":"Marshall","year":"2016","journal-title":"Mol Cancer"},{"key":"B51","doi-asserted-by":"publisher","first-page":"R95","DOI":"10.1186\/bcr2195","article-title":"IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines","volume":"10","author":"Zhu","year":"2008","journal-title":"Breast Cancer Res"},{"key":"B52","article-title":"IL-17 Expression by macrophages is associated with proliferative inflammatory atrophy lesions in prostate cancer patients","volume":"4","author":"Vykhovanets","year":"2011","journal-title":"Int J Clin Exp Pathol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.18632\/aging.204208","article-title":"Interleukin-17D promotes lung cancer progression by inducing tumor-associated macrophage infiltration via the p38 MAPK signaling pathway","volume":"14","author":"Lin","year":"2022","journal-title":"Aging (Albany NY)"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3182542752","article-title":"Interleukin-17 and prostaglandin E2 are involved in formation of an M2 macrophage-dominant microenvironment in lung cancer","volume":"7","author":"Liu","year":"2012","journal-title":"J Thorac Oncol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e0044723","DOI":"10.1128\/mbio.00447-23","article-title":"Candida albicans Promotes Oral Cancer via IL-17A\/IL-17RA-Macrophage Axis","volume":"14","author":"Wang","year":"2023","journal-title":"Mbio"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e106834","DOI":"10.1371\/journal.pone.0106834","article-title":"Intratumor IL-17-positive mast cells are the major source of the IL-17 that is predictive of survival in gastric cancer patients","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.5435","article-title":"IL-17 producing mast cells promote the expansion of myeloid-derived suppressor cells in a mouse allergy model of colorectal cancer","volume":"6","author":"Chen","year":"2015","journal-title":"Oncotarget"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-013-1460-4","article-title":"Mast cells expressing interleukin 17 in the muscularis propria predict a favorable prognosis in esophageal squamous cell carcinoma","volume":"62","author":"Wang","year":"2013","journal-title":"Cancer Immunol Immunother"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2017.28","article-title":"IL-17C mediates the recruitment of tumor-associated neutrophils and lung tumor growth","volume":"36","author":"Jungnickel","year":"2017","journal-title":"Oncogene"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20210693","article-title":"IL-17-induced HIF1alpha drives resistance to anti-PD-L1 via fibroblast-mediated immune exclusion","volume":"219","author":"Chen","year":"2022","journal-title":"J Exp Med"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/srep16053","article-title":"Interleukin-17 promotes angiogenesis by stimulating VEGF production of cancer cells via the STAT3\/GIV signaling pathway in non-small-cell lung cancer","volume":"5","author":"Pan","year":"2015","journal-title":"Sci Rep"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.175.9.6177","article-title":"IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis","volume":"175","author":"Numasaki","year":"2005","journal-title":"J Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.9.6536","article-title":"Differential regulation of chemokines by IL-17 in colonic epithelial cells","volume":"181","author":"Lee","year":"2008","journal-title":"J Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3390\/genes13091643","article-title":"Interleukin-17 family cytokines in metabolic disorders and cancer","volume":"13","author":"Meehan","year":"2022","journal-title":"Genes (Basel)"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0514-y","article-title":"IL-17 receptor-based signaling and implications for disease","volume":"20","author":"Li","year":"2019","journal-title":"Nat Immunol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M700499200","article-title":"Identification of an interleukin 17F\/17A heterodimer in activated human CD4+ T cells","volume":"282","author":"Wright","year":"2007","journal-title":"J Biol Chem"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110757","article-title":"IL-17A functions and the therapeutic use of IL-17A and IL-17RA targeted antibodies for cancer treatment","volume":"123","author":"Song","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2023.119547","article-title":"IL-17 promotes melanoma through TRAF2 as a scaffold protein recruiting PIAS2 and ELAVL1 to induce EPHA5","volume":"1870","author":"Du","year":"2023","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00184-7","article-title":"Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis","volume":"397","author":"Ghoreschi","year":"2021","journal-title":"Lancet"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2015.53","article-title":"The IL-23-IL-17 axis in inflammatory arthritis","volume":"11","author":"Lubberts","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-018-0091-8","article-title":"Effects of the IL-23-IL-17 pathway on bone in spondyloarthritis","volume":"14","author":"Gravallese","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-021-00644-5","article-title":"Local and systemic effects of IL-17 in joint inflammation: a historical perspective from discovery to targeting","volume":"18","author":"Miossec","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21248","article-title":"IL-23\/IL-17 axis in IBD","volume":"16","author":"Sarra","year":"2010","journal-title":"Inflammation Bowel Dis"},{"key":"B74","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.smim.2017.09.006","article-title":"Microbiome, inflammation and colorectal cancer","volume":"32","author":"Chen","year":"2017","journal-title":"Semin Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjab102","article-title":"Inflammatory bowel disease-associated colorectal cancer: translational risks from mechanisms to medicines","volume":"15","author":"Porter","year":"2021","journal-title":"J Crohns Colitis"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v26.i38.5759","article-title":"Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma","volume":"26","author":"D'Souza","year":"2020","journal-title":"World J Gastroenterol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-023-09838-w","article-title":"Exploring the role of the inflammasomes on prostate cancer: Interplay with obesity","volume":"24","author":"Perez-Gomez","year":"2023","journal-title":"Rev Endocr Metab Disord"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/2953191","article-title":"IL-17 Affects the Progression, Metastasis, and Recurrence of Laryngeal Cancer via the Inhibition of Apoptosis through Activation of the PI3K\/AKT\/FAS\/FASL Pathways","volume":"2020","author":"Song","year":"2020","journal-title":"J Immunol Res"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190297","article-title":"The role of interleukin-17 in tumor development and progression","volume":"217","author":"Zhao","year":"2020","journal-title":"J Exp Med"},{"key":"B80","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s10120-022-01342-5","article-title":"IL-17A promotes Helicobacter pylori-induced gastric carcinogenesis via interactions with IL-17RC","volume":"26","author":"Kang","year":"2023","journal-title":"Gastric Cancer"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.228","article-title":"Targeting IL-17A in multiple myeloma: a potential novel therapeutic approach in myeloma","volume":"30","author":"Prabhala","year":"2016","journal-title":"Leukemia"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0134-y","article-title":"Suppression of IL-17F, but not of IL-17A, provides protection against colitis by inducing T(reg) cells through modification of the intestinal microbiota","volume":"19","author":"Tang","year":"2018","journal-title":"Nat Immunol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12142","article-title":"Interleukin-17A: a unique pathway in immune-mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis","volume":"141","author":"Kirkham","year":"2014","journal-title":"Immunology"},{"key":"B84","article-title":"Increased chemokine receptor IL-17RA expression is associated with poor survival in gastric cancer patients","volume":"8","author":"Jiang","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32122","article-title":"IL-17R deletion predicts high-grade colorectal cancer and poor clinical outcomes","volume":"145","author":"Yan","year":"2019","journal-title":"Int J Cancer"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.7296","article-title":"Hyperinsulinemia enhances interleukin-17-induced inflammation to promote prostate cancer development in obese mice through inhibiting glycogen synthase kinase 3-mediated phosphorylation and degradation of interleukin-17 receptor","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.12.016","article-title":"IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease","volume":"72","author":"Ma","year":"2020","journal-title":"J Hepatol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1038\/srep25447","article-title":"Non-tumor tissue derived interleukin-17B activates IL-17RB\/AKT\/beta-catenin pathway to enhance the stemness of gastric cancer","volume":"6","author":"Bie","year":"2016","journal-title":"Sci Rep"},{"key":"B89","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.canlet.2018.02.037","article-title":"A positive feedback loop of IL-17B-IL-17RB activates ERK\/beta-catenin to promote lung cancer metastasis","volume":"422","author":"Yang","year":"2018","journal-title":"Cancer Lett"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abc2823","article-title":"Characterization of initial key steps of IL-17 receptor B oncogenic signaling for targeted therapy of pancreatic cancer","volume":"13","author":"Wu","year":"2021","journal-title":"Sci Transl Med"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20141702","article-title":"Targeting IL-17B-IL-17RB signaling with an anti-IL-17RB antibody blocks pancreatic cancer metastasis by silencing multiple chemokines","volume":"212","author":"Wu","year":"2015","journal-title":"J Exp Med"},{"key":"B92","article-title":"Expression of IL-17A, E, and F and their receptors in non-small-cell lung cancer","volume":"32","author":"Huang","year":"2018","journal-title":"J Biol Regul Homeost Agents"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1593\/neo.07109","article-title":"Differential expression of IL-17RC isoforms in androgen-dependent and androgen-independent prostate cancers","volume":"9","author":"You","year":"2007","journal-title":"Neoplasia"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-1130","article-title":"Interleukin-17 receptor-like gene is a novel antiapoptotic gene highly expressed in androgen-independent prostate cancer","volume":"66","author":"You","year":"2006","journal-title":"Cancer Res"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1002\/1873-3468.14266","article-title":"IL-17RD\/sef exacerbates experimental mouse colitis and inflammation-associated tumorigenesis by regulating the proportion of T cell subsets","volume":"596","author":"Fu","year":"2022","journal-title":"FEBS Lett"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209428","article-title":"Loss of Sef (similar expression to FGF) expression is associated with high grade and metastatic prostate cancer","volume":"25","author":"Darby","year":"2006","journal-title":"Oncogene"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.25532","article-title":"Sef regulates epithelial-mesenchymal transition in breast cancer cells","volume":"117","author":"He","year":"2016","journal-title":"J Cell Biochem"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-0171","article-title":"miR-193a-3p is a key tumor suppressor in ulcerative colitis-associated colon cancer and promotes carcinogenesis through upregulation of IL17RD","volume":"23","author":"Pekow","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1186\/1756-9966-32-3","article-title":"High expression of IL-17 and IL-17RE associate with poor prognosis of hepatocellular carcinoma","volume":"32","author":"Liao","year":"2013","journal-title":"J Exp Clin Cancer Res"},{"key":"B100","doi-asserted-by":"publisher","first-page":"78ra31","DOI":"10.1126\/scitranslmed.3001374","article-title":"IL-25 causes apoptosis of IL-25R-expressing breast cancer cells without toxicity to nonmalignant cells","volume":"3","author":"Furuta","year":"2011","journal-title":"Sci Transl Med"},{"key":"B101","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s40425-019-0757-z","article-title":"IL-17 inhibits CXCL9\/10-mediated recruitment of CD8(+) cytotoxic T cells and regulatory T cells to colorectal tumors","volume":"7","author":"Chen","year":"2019","journal-title":"J Immunother Cancer"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.11.009","article-title":"Interleukin-17 receptor a signaling in transformed enterocytes promotes early colorectal tumorigenesis","volume":"41","author":"Wang","year":"2014","journal-title":"Immunity"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-019-02445-2","article-title":"IL-17A promotes fatty acid uptake through the IL-17A\/IL-17RA\/p-STAT3\/FABP4 axis to fuel ovarian cancer growth in an adipocyte-rich microenvironment","volume":"69","author":"Yu","year":"2020","journal-title":"Cancer Immunol Immunother"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/4910595","article-title":"Expression Levels of IL-17A, IL-17F, IL-17RA, and IL-17RC in Prostate Cancer with Taking into Account the Histological Grade according to Gleason Scale in Comparison to Benign Prostatic Hyperplasia: In Search of New Therapeutic Options","volume":"2020","author":"Janiczek","year":"2020","journal-title":"J Immunol Res"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-020-01540-4","article-title":"Loss of interleukin-17 receptor D promotes chronic inflammation-associated tumorigenesis","volume":"40","author":"Girondel","year":"2021","journal-title":"Oncogene"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210424","article-title":"Downregulation of Sef, an inhibitor of receptor tyrosine kinase signaling, is common to a variety of human carcinomas","volume":"26","author":"Zisman-Rozen","year":"2007","journal-title":"Oncogene"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/623759","article-title":"The role of interleukin 17 in tumour proliferation, angiogenesis, and metastasis","volume":"2014","author":"Yang","year":"2014","journal-title":"Mediators Inflammation"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-05-1461","article-title":"Interleukin-17 promotes angiogenesis and tumor growth","volume":"101","author":"Numasaki","year":"2003","journal-title":"Blood"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-09-177360","article-title":"Endogenous IL-17 contributes to reduced tumor growth and metastasis","volume":"114","author":"Kryczek","year":"2009","journal-title":"Blood"},{"key":"B110","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/s12967-023-04187-3","article-title":"IL-17A-mediated mitochondrial dysfunction induces pyroptosis in colorectal cance cells and promotes CD8 + T-cell tumour infiltration","volume":"21","author":"Feng","year":"2023","journal-title":"J Transl Med"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034959","article-title":"A protective role by interleukin-17F in colon tumorigenesis","volume":"7","author":"Tong","year":"2012","journal-title":"PLoS One"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-021-02867-x","article-title":"Interleukin 17A promotes cell migration, enhances anoikis resistance, and creates a microenvironment suitable for triple negative breast cancer tumor metastasis","volume":"70","author":"Tsai","year":"2021","journal-title":"Cancer Immunol Immunother"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107544","article-title":"The potential role and status of IL-17 family cytokines in breast cancer","volume":"95","author":"Song","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2019.09.016","article-title":"IL-17\u2013CXC chemokine receptor 2 axis facilitates breast cancer progression by up-regulating neutrophil recruitment","volume":"190","author":"Wu","year":"2020","journal-title":"Am J Pathol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1007\/s12282-023-01467-0","article-title":"Interleukin (IL)-17A in triple-negative breast cancer: a potent prognostic factor associated with intratumoral neutrophil infiltration","volume":"30","author":"Khalid","year":"2023","journal-title":"Breast Cancer"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.23008","article-title":"The IL-17B-IL-17 receptor B pathway promotes resistance to paclitaxel in breast tumors through activation of the ERK1\/2 pathway","volume":"8","author":"Laprevotte","year":"2017","journal-title":"Ecollection"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1038\/srep11874","article-title":"IL-17A and its homologs IL-25\/IL-17E recruit the c-RAF\/S6 kinase pathway and the generation of pro-oncogenic LMW-E in breast cancer cells","volume":"5","author":"Mombelli","year":"2015","journal-title":"Sci Rep"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17091433","article-title":"Targeting the tumor microenvironment: the protumor effects of IL-17 related to cancer type","volume":"17","author":"Fabre","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B119","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1186\/s12967-023-04365-3","article-title":"IL-17A promotes tumorigenesis and upregulates PD-L1 expression in non-small cell lung cancer","volume":"21","author":"Liao","year":"2023","journal-title":"J Transl Med"},{"key":"B120","article-title":"Interleukin-17-induced EMT promotes lung cancer cell migration and invasion via NF-kappaB\/ZEB1 signal pathway","volume":"5","author":"Gu","year":"2015","journal-title":"Am J Cancer Res"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1461303","article-title":"Th17 cell-derived IL-17A promoted tumor progression via STAT3\/NF-kappaB\/Notch1 signaling in non-small cell lung cancer","volume":"7","author":"Wang","year":"2018","journal-title":"Oncoimmunology"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00125.2014","article-title":"Promotion of lung tumor growth by interleukin-17","volume":"307","author":"Xu","year":"2014","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/8494079","article-title":"The role of interleukin-17 in lung cancer","volume":"2016","author":"Wu","year":"2016","journal-title":"Mediators Inflammation"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2012.10.011","article-title":"IL-17 promoted metastasis of non-small-cell lung cancer cells","volume":"148","author":"Li","year":"2012","journal-title":"Immunol Lett"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.109871","article-title":"P-STAT3 and IL-17 in tumor tissues enhances the prognostic value of CEA and CA125 in patients with lung adenocarcinoma","volume":"125","author":"Chen","year":"2020","journal-title":"BioMed Pharmacother"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2017.04.017","article-title":"Interleukin-17A promotes lung tumor progression through neutrophil attraction to tumor sites and mediating resistance to PD-1 blockade","volume":"12","author":"Akbay","year":"2017","journal-title":"J Thorac Oncol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024856","article-title":"Involvement of CCR6\/CCL20\/IL-17 axis in NSCLC disease progression","volume":"6","author":"Kirshberg","year":"2011","journal-title":"PLoS One"},{"key":"B128","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1164\/rccm.201310-1776OC","article-title":"Interplay of Th1 and Th17 cells in murine models of Malignant pleural effusion","volume":"189","author":"Lin","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-0307","article-title":"Immunotherapy with PI3K inhibitor and toll-like receptor agonist induces IFN-\u03b3+IL-17+ Polyfunctional T cells that mediate rejection of murine tumors","volume":"72","author":"Marshall","year":"2012","journal-title":"Cancer Res (Chicago Ill.)"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.70408","article-title":"Interleukin-17 programs liver progenitor cell transformation into cancer stem cells through miR-122 downregulation with increased risk of primary liver cancer initiation","volume":"18","author":"Gasmi","year":"2022","journal-title":"Int J Biol Sci"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2011.04471.x","article-title":"Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease","volume":"166","author":"Tang","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-10-150","article-title":"IL-17 induces AKT-dependent IL-6\/JAK2\/STAT3 activation and tumor progression in hepatocellular carcinoma","volume":"10","author":"Gu","year":"2011","journal-title":"Mol Cancer"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0021816","article-title":"Interleukin 17A promotes hepatocellular carcinoma metastasis via NF-kB induced matrix metalloproteinases 2 and 9 expression","volume":"6","author":"Li","year":"2011","journal-title":"PLoS One"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.08.041","article-title":"Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma","volume":"54","author":"Kuang","year":"2011","journal-title":"J Hepatol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2019.11.134","article-title":"IL-17 promotes hepatocellular carcinoma through inhibiting apoptosis induced by IFN-gamma","volume":"522","author":"Li","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.17973","article-title":"M2 tumor-associated macrophages produce interleukin-17 to suppress oxaliplatin-induced apoptosis in hepatocellular carcinoma","volume":"8","author":"Guo","year":"2017","journal-title":"Oncotarget"},{"key":"B137","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.bbrc.2018.12.103","article-title":"IL-17A inhibits autophagic activity of HCC cells by inhibiting the degradation of Bcl2","volume":"509","author":"Li","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"B138","doi-asserted-by":"publisher","first-page":"598","DOI":"10.3109\/07357900903287030","article-title":"Interleukin-17F suppresses hepatocarcinoma cell growth via inhibition of tumor angiogenesis","volume":"28","author":"Xie","year":"2010","journal-title":"Cancer Invest"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.10251","article-title":"MMP7 interacts with ARF in nucleus to potentiate tumor microenvironments for prostate cancer progression in vivo","volume":"7","author":"Xie","year":"2016","journal-title":"Oncotarget"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-3795","article-title":"Interleukin-17 promotes formation and growth of prostate adenocarcinoma in mouse models","volume":"72","author":"Zhang","year":"2012","journal-title":"Cancer Res"},{"key":"B141","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.imlet.2017.02.006","article-title":"Inflammatory cytokines IL-17 and TNF-alpha up-regulate PD-L1 expression in human prostate and colon cancer cells","volume":"184","author":"Wang","year":"2017","journal-title":"Immunol Lett"},{"key":"B142","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/s41419-022-05215-8","article-title":"Cathepsin K regulates the tumor growth and metastasis by IL-17\/CTSK\/EMT axis and mediates M2 macrophage polarization in castration-resistant prostate cancer","volume":"13","author":"Wu","year":"2022","journal-title":"Cell Death Dis"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1002\/pros.22971","article-title":"IL-17 and insulin\/IGF1 enhance adhesion of prostate cancer cells to vascular endothelial cells through CD44-VCAM-1 interaction","volume":"75","author":"Chen","year":"2015","journal-title":"Prostate"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S304298","article-title":"Comprehensive analysis of the relationship between metabolic reprogramming and immune function in prostate cancer","volume":"14","author":"Xie","year":"2021","journal-title":"Onco Targets Ther"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1002\/cbin.11651","article-title":"Comparing the frequency of CD33(+) pSTAT3(+) myeloid-derived suppressor cells and IL-17(+) lymphocytes in patients with prostate cancer and benign prostatic hyperplasia","volume":"45","author":"Sanaei","year":"2021","journal-title":"Cell Biol Int"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0902574","article-title":"IL-17 promotes tumor development through the induction of tumor promoting microenvironments at tumor sites and myeloid-derived suppressor cells","volume":"184","author":"He","year":"2010","journal-title":"J Immunol"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1002\/pros.22805","article-title":"Interleukin-17 promotes development of castration-resistant prostate cancer potentially through creating an immunotolerant and pro-angiogenic tumor microenvironment","volume":"74","author":"Zhang","year":"2014","journal-title":"Prostate"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1111\/and.13750","article-title":"IL-17F facilitates prostate cancer cell Malignant phenotypes via activation of the PI3K\/AKT signalling pathway","volume":"52","author":"Zhu","year":"2020","journal-title":"Andrologia"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2013.537","article-title":"Interleukin-17 produced by tumor microenvironment promotes self-renewal of CD133+ cancer stem-like cells in ovarian cancer","volume":"34","author":"Xiang","year":"2015","journal-title":"Oncogene"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14174","article-title":"Interleukin-17 is associated with expression of programmed cell death 1 ligand 1 in ovarian carcinoma","volume":"110","author":"Aotsuka","year":"2019","journal-title":"Cancer Sci"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1172\/JCI39065","article-title":"The tumor-promoting actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in mice and humans","volume":"119","author":"Charles","year":"2009","journal-title":"J Clin Invest"},{"key":"B152","article-title":"Interleukin-17 promotes the development of ovarian cancer through upregulation of MTA1 expression","volume":"12","author":"Guo","year":"2022","journal-title":"Am J Cancer Res"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1604","article-title":"Reciprocal crosstalk between Th17 and mesothelial cells promotes metastasis-associated adhesion of ovarian cancer cells","volume":"14","author":"Neuhaus","year":"2024","journal-title":"Clin Transl Med"},{"key":"B154","doi-asserted-by":"publisher","first-page":"4943","DOI":"10.1038\/s41467-022-32627-z","article-title":"scRNA-seq of gastric tumor shows complex intercellular interaction with an alternative T cell exhaustion trajectory","volume":"13","author":"Sun","year":"2022","journal-title":"Nat Commun"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2016.291","article-title":"The promotion of the transformation of quiescent gastric cancer stem cells by IL-17 and the underlying mechanisms","volume":"36","author":"Jiang","year":"2017","journal-title":"Oncogene"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-015-4372-4","article-title":"IL-17 promotes tumor angiogenesis through Stat3 pathway mediated upregulation of VEGF in gastric cancer","volume":"37","author":"Wu","year":"2016","journal-title":"Tumour Biol"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-0617","article-title":"Interleukin-17-producing neutrophils link inflammatory stimuli to disease progression by promoting angiogenesis in gastric cancer","volume":"23","author":"Li","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190354","article-title":"Interleukin-17-induced neutrophil extracellular traps mediate resistance to checkpoint blockade in pancreatic cancer","volume":"217","author":"Zhang","year":"2020","journal-title":"J Exp Med"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.03.041","article-title":"Immune cell production of interleukin 17 induces stem cell features of pancreatic intraepithelial neoplasia cells","volume":"155","author":"Zhang","year":"2018","journal-title":"Gastroenterology"},{"key":"B160","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2021.03.003","article-title":"Interleukin-17 activates and synergizes with the notch signaling pathway in the progression of pancreatic ductal adenocarcinoma","volume":"508","author":"Wang","year":"2021","journal-title":"Cancer Lett"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-0896","article-title":"IL17 functions through the novel REG3beta-JAK2-STAT3 inflammatory pathway to promote the transition from chronic pancreatitis to pancreatic cancer","volume":"75","author":"Loncle","year":"2015","journal-title":"Cancer Res"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13215338","article-title":"IL-17B\/RB activation in pancreatic stellate cells promotes pancreatic cancer metabolism and growth","volume":"13","author":"Li","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.3892\/or.2017.5426","article-title":"Interleukin-17A promotes esophageal adenocarcinoma cell invasiveness through ROS-dependent, NF-kappaB-mediated MMP-2\/9 activation","volume":"37","author":"Liu","year":"2017","journal-title":"Oncol Rep"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018219","article-title":"The accumulation and prognosis value of tumor infiltrating IL-17 producing cells in esophageal squamous cell carcinoma","volume":"6","author":"Lv","year":"2011","journal-title":"PLoS One"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0b013e3182a802cf","article-title":"IL-17A promotes immune cell recruitment in human esophageal cancers and the infiltrating dendritic cells represent a positive prognostic marker for patient survival","volume":"36","author":"Lu","year":"2013","journal-title":"J Immunother"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.7869","article-title":"IL-17A promotes migration and tumor killing capability of B cells in esophageal squamous cell carcinoma","volume":"7","author":"Lu","year":"2016","journal-title":"Oncotarget"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/713859","article-title":"Hmgb1-IL-23-IL-17-IL-6-Stat3 axis promotes tumor growth in murine models of melanoma","volume":"2013","author":"Tang","year":"2013","journal-title":"Mediators Inflammation"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002603","article-title":"Type 17 immunity promotes the exhaustion of CD8(+) T cells in cancer","volume":"9","author":"Kim","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-023-00610-2","article-title":"Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma","volume":"4","author":"Varaljai","year":"2023","journal-title":"Nat Cancer"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.23934","article-title":"Interleukin 17 and peripheral IL-17-expressing T cells are negatively correlated with the overall survival of head and neck cancer patients","volume":"9","author":"Lee","year":"2018","journal-title":"Oncotarget"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108343","article-title":"The increased IL-17-producing gammadeltaT cells promote tumor cell proliferation and migration in neuroblastoma","volume":"211","author":"Zhang","year":"2020","journal-title":"Clin Immunol"},{"key":"B172","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1136\/gutjnl-2015-310016","article-title":"Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer","volume":"66","author":"Amicarella","year":"2017","journal-title":"Gut"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1038\/nature11465","article-title":"Adenoma-linked barrier defects and microbial products drive IL-23\/IL-17-mediated tumour growth","volume":"491","author":"Grivennikov","year":"2012","journal-title":"Nature"},{"key":"B174","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.cyto.2018.12.021","article-title":"IL-17 and colorectal cancer: From carcinogenesis to treatment","volume":"116","author":"Razi","year":"2019","journal-title":"Cytokine"},{"key":"B175","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41389-023-00492-0","article-title":"Molecular mechanisms in colitis-associated colorectal cancer","volume":"12","author":"Zhou","year":"2023","journal-title":"Oncogenesis"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgs106","article-title":"Role of IL-17A in the development of colitis-associated cancer","volume":"33","author":"Hyun","year":"2012","journal-title":"Carcinogenesis"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2011.09.016","article-title":"IL-17F deficiency inhibits small intestinal tumorigenesis in ApcMin\/+ mice","volume":"414","author":"Chae","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0912675107","article-title":"Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis","volume":"107","author":"Chae","year":"2010","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10071710","article-title":"Mouse models for application in colorectal cancer: understanding the pathogenesis and relevance to the human condition","volume":"10","author":"Li","year":"2022","journal-title":"Biomedicines"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-2735","article-title":"Mouse model of colonic adenoma-carcinoma progression based on somatic Apc inactivation","volume":"67","author":"Hinoi","year":"2007","journal-title":"Cancer Res"},{"key":"B181","article-title":"The IL-23 to IL-17 cascade inflammation-related cancers","volume":"33","author":"Wang","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"B182","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nature18848","article-title":"The microbiota in adaptive immune homeostasis and disease","volume":"535","author":"Honda","year":"2016","journal-title":"Nature"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1051\/medsci\/2010264352","article-title":"Induction of gut mucosal Th17 cells by segmented filamentous bacteria","volume":"26","author":"Ivanov","year":"2010","journal-title":"Med Sci (Paris)"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02750","article-title":"Induction of intestinal th17 cells by flagellins from segmented filamentous bacteria","volume":"10","author":"Wang","year":"2019","journal-title":"Front Immunol"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-019-0312-y","article-title":"Gut microbiota-stimulated cathepsin K secretion mediates TLR4-dependent M2 macrophage polarization and promotes tumor metastasis in colorectal cancer","volume":"26","author":"Li","year":"2019","journal-title":"Cell Death Differ"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-023-01363-5","article-title":"Microbiota-derived tryptophan catabolites mediate the chemopreventive effects of statins on colorectal cancer","volume":"8","author":"Han","year":"2023","journal-title":"Nat Microbiol"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.11.018","article-title":"Alterations in the microbiota drive interleukin-17C production from intestinal epithelial cells to promote tumorigenesis","volume":"40","author":"Song","year":"2014","journal-title":"Immunity"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2016.5329","article-title":"Effect of IL-17 in the development of colon cancer in mice","volume":"12","author":"Yang","year":"2016","journal-title":"Oncol Lett"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20071978","article-title":"Regulation of inflammatory responses by IL-17F","volume":"205","author":"Yang","year":"2008","journal-title":"J Exp Med"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222212144","article-title":"Multiple roles of the interleukin IL-17 members in breast cancer and beyond","volume":"22","author":"Bruno","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B191","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1158\/2159-8290.CD-20-0263","article-title":"Lower airway dysbiosis affects lung cancer progression","volume":"11","author":"Tsay","year":"2021","journal-title":"Cancer Discovery"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.102429","article-title":"Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies","volume":"19","author":"Ruiz","year":"2020","journal-title":"Autoimmun Rev"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens11010057","article-title":"Elevated levels of IL-33, IL-17 and IL-25 indicate the progression from chronicity to hepatocellular carcinoma in hepatitis C virus patients","volume":"11","author":"Askoura","year":"2022","journal-title":"Pathogens"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2018.06.008","article-title":"IL-17 and IL-17-producing cells and liver diseases, with focus on autoimmune liver diseases","volume":"17","author":"Beringer","year":"2018","journal-title":"Autoimmun Rev"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.02.011","article-title":"Battling IL-17, the troublemaker in alcohol-induced hepatocellular carcinoma","volume":"72","author":"Bansal","year":"2020","journal-title":"J Hepatol"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-024-00825-z","article-title":"Targeting the tumor microenvironment, a new therapeutic approach for prostate cancer","author":"Fang","year":"2024","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"B197","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s11658-024-00591-9","article-title":"The role of proinflammatory cytokines and CXC chemokines (CXCL1-CXCL16) in the progression of prostate cancer: insights on their therapeutic management","volume":"29","author":"Ullah","year":"2024","journal-title":"Cell Mol Biol Lett"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy505","article-title":"Intratumoral IL17-producing cells infiltration correlate with antitumor immune contexture and improved response to adjuvant chemotherapy in gastric cancer","volume":"30","author":"Wang","year":"2019","journal-title":"Ann Oncol"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1007\/s00251-023-01318-4","article-title":"Increased circulating Th17 cell populations in patients with pancreatic ductal adenocarcinoma","volume":"75","author":"Khan","year":"2023","journal-title":"Immunogenetics"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190456","article-title":"Targeting the interleukin-17 immune axis for cancer immunotherapy","volume":"217","author":"Vitiello","year":"2020","journal-title":"J Exp Med"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1038\/srep03456","article-title":"IL-17A is produced by breast cancer TILs and promotes chemoresistance and proliferation through ERK1\/2","volume":"3","author":"Cochaud","year":"2013","journal-title":"Sci Rep"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.10804","article-title":"IL-17E synergizes with EGF and confers in vitro resistance to EGFR-targeted therapies in TNBC cells","volume":"7","author":"Merrouche","year":"2016","journal-title":"Oncotarget"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2019.09.016","article-title":"IL-17-CXC chemokine receptor 2 axis facilitates breast cancer progression by up-regulating neutrophil recruitment","volume":"190","author":"Wu","year":"2020","journal-title":"Am J Pathol"},{"key":"B204","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/s41467-020-14698-y","article-title":"Inflammation mobilizes copper metabolism to promote colon tumorigenesis via an IL-17-STEAP4-XIAP axis","volume":"11","author":"Liao","year":"2020","journal-title":"Nat Commun"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.9645","article-title":"Interleukin-17 promotes the development of cisplatin resistance in colorectal cancer","volume":"17","author":"Sui","year":"2019","journal-title":"Oncol Lett"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3291","article-title":"An interleukin-17-mediated paracrine network promotes tumor resistance to anti-angiogenic therapy","volume":"19","author":"Chung","year":"2013","journal-title":"Nat Med"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2005010117","article-title":"CD4 T cell-intrinsic role for the T helper 17 signature cytokine IL-17: Effector resistance to immune suppression","volume":"117","author":"Crawford","year":"2020","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-020-02795-2","article-title":"Anti-PD-1 antibody-mediated activation of type 17 T-cells undermines checkpoint blockade therapy","volume":"70","author":"Li","year":"2021","journal-title":"Cancer Immunol Immunother"},{"key":"B209","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.aan4236","article-title":"Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients","volume":"359","author":"Gopalakrishnan","year":"2018","journal-title":"Science"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2021.152068","article-title":"The interplay of interleukin-17A and breast cancer tumor microenvironment as a novel immunotherapeutic approach to increase tumor immunogenicity","volume":"226","author":"Moaaz","year":"2021","journal-title":"Immunobiology"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2022.188758","article-title":"Targeting interleukin-17 enhances tumor response to immune checkpoint inhibitors in colorectal cancer","volume":"1877","author":"Li","year":"2022","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001895","article-title":"Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer","volume":"9","author":"Liu","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1016\/j.clcc.2017.10.003","article-title":"Monoclonal antibodies targeting the IL-17\/IL-17RA axis: an opportunity to improve the efficiency of anti-VEGF therapy in fighting metastatic colorectal cancer","volume":"17","author":"Ibrahim","year":"2018","journal-title":"Clin Colorectal Cancer"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-301668","article-title":"Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial","volume":"61","author":"Hueber","year":"2012","journal-title":"Gut"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2016.298","article-title":"A randomized, double-blind, placebo-controlled phase 2 study of brodalumab in patients with moderate-to-severe crohn's disease","volume":"111","author":"Targan","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.09.003","article-title":"Interleukin-23-independent IL-17 production regulates intestinal epithelial permeability","volume":"43","author":"Lee","year":"2015","journal-title":"Immunity"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.08.019","article-title":"Differential roles for interleukin-23 and interleukin-17 in intestinal immunoregulation","volume":"43","author":"Maxwell","year":"2015","journal-title":"Immunity"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.10.001","article-title":"Gut-busters: IL-17 ain't afraid of no IL-23","volume":"43","author":"Whibley","year":"2015","journal-title":"Immunity"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1703047","article-title":"Reversal of autoimmune toxicity and loss of tumor response by interleukin-17 blockade","volume":"376","author":"Esfahani","year":"2017","journal-title":"N Engl J Med"},{"key":"B220","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3324\/haematol.2011.047316","article-title":"Th17 and non-Th17 interleukin-17-expressing cells in chronic lymphocytic leukemia: delineation, distribution, and clinical relevance","volume":"97","author":"Jain","year":"2012","journal-title":"Haematologica"},{"key":"B221","doi-asserted-by":"publisher","first-page":"7614","DOI":"10.18632\/oncotarget.13819","article-title":"Targeting of interleukin (IL)-17A inhibits PDL1 expression in tumor cells and induces anticancer immunity in an estrogen receptor-negative murine model of breast cancer","volume":"8","author":"Ma","year":"2016","journal-title":"Oncotarget"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2023.08.034","article-title":"Cancer immunotherapy with enveloped self-amplifying mRNA CARG-2020 that modulates IL-12, IL-17 and PD-L1 pathways to prevent tumor recurrence","volume":"14","author":"Chen","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"B223","doi-asserted-by":"publisher","first-page":"10353","DOI":"10.1038\/s41598-019-46759-8","article-title":"IL-17C-mediated innate inflammation decreases the response to PD-1 blockade in a model of Kras-driven lung cancer","volume":"9","author":"Ritzmann","year":"2019","journal-title":"Sci Rep"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20211431","article-title":"PD-1 and TIM-3 differentially regulate subsets of mouse IL-17A-producing gammadelta T cells","volume":"220","author":"Edwards","year":"2023","journal-title":"J Exp Med"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-0307","article-title":"Immunotherapy with PI3K inhibitor and Toll-like receptor agonist induces IFN-gamma+IL-17+ polyfunctional T cells that mediate rejection of murine tumors","volume":"72","author":"Marshall","year":"2012","journal-title":"Cancer Res"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-023-00611-1","article-title":"Immunotherapy responses of patients with metastatic melanoma are linked to IL-17 signaling","volume":"4","author":"V\u00e1raljai","year":"2023","journal-title":"Nat Cancer"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2017.124","article-title":"Rituximab or irradiation promotes IL-17 secretion and thereby induces resistance to rituximab or irradiation","volume":"14","author":"Zhong","year":"2017","journal-title":"Cell Mol Immunol"},{"key":"B228","doi-asserted-by":"publisher","first-page":"11586","DOI":"10.1038\/s41598-017-11656-5","article-title":"The Th1\/Th17 balance dictates the fibrosis response in murine radiation-induced lung disease","volume":"7","author":"Paun","year":"2017","journal-title":"Sci Rep"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20092121","article-title":"Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent","volume":"207","author":"Wilson","year":"2010","journal-title":"J Exp Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1479505\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T03:37:50Z","timestamp":1737430670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1479505\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,21]]},"references-count":229,"alternative-id":["10.3389\/fimmu.2024.1479505"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1479505","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,21]]},"article-number":"1479505"}}